Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.441.541.802.102.69

What is the latest Fixed Capital/Sales ratio of ORCHID PHARMA ?

The latest Fixed Capital/Sales ratio of ORCHID PHARMA is 1.44 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.44
Mar20241.54
Mar20231.80
Mar20222.10
Mar20212.69

How is Fixed Capital/Sales of ORCHID PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.44
-6.49
Mar2024 1.54
-14.44
Mar2023 1.8
-14.29
Mar2022 2.1
-21.93
Mar2021 2.69 -

Other Financial Ratios of ORCHID PHARMA


Compare Fixed Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,558.6 Cr -1.1% -25.3% -44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.1%

-25.3%

-44.3%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses